These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24855688)

  • 1. Perceptions of emtricitabine-tenofovir in HIV PrEP.
    Kruse L; Stover K; Henderson H
    HIV Clin; 2014; 26(1):1, 4-7. PubMed ID: 24855688
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA paves the way for pre-exposure HIV prophylaxis.
    Holmes D
    Lancet; 2012 Jul; 380(9839):325. PubMed ID: 22852138
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV preexposure prophylaxis: new data and potential use.
    Celum CL
    Top Antivir Med; 2011 Dec; 19(5):181-5. PubMed ID: 22298887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pre-exposure prophylaxis for HIV transmission? No, unless].
    Boeke AJ; Heijnen AM
    Ned Tijdschr Geneeskd; 2013; 157(27):A6359. PubMed ID: 23838404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].
    Boot J; Rump BO; Boucher CA; Op de Coul EL; van Agtmael MA; van de Vijver DA; Burger DM; Fanoy EB
    Ned Tijdschr Geneeskd; 2013; 157(27):A6063. PubMed ID: 23838402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis.
    Keller SB; Smith DM
    AIDS; 2011 Nov; 25(18):2308-10. PubMed ID: 22067201
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing HIV in women--still trying to find their VOICE.
    Saag MS
    N Engl J Med; 2015 Feb; 372(6):564-6. PubMed ID: 25651251
    [No Abstract]   [Full Text] [Related]  

  • 9. Study halted: no benefit seen from antiretroviral pill in preventing HIV in women.
    Stephenson J
    JAMA; 2011 May; 305(19):1952. PubMed ID: 21586708
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV preexposure prophylaxis in the real world.
    Daskalakis DC
    Top Antivir Med; 2014; 22(4):670-5. PubMed ID: 25398067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine.
    Amoroso A; Gilliam BL; Talwani R; Boyce C; Redfield RR; Davis CE
    HIV Clin Trials; 2009; 10(5):320-3. PubMed ID: 19906624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
    Dolling D; Phillips AN; Delpech V; Pillay D; Cane PA; Crook AM; Shepherd J; Fearnhill E; Hill T; Dunn D; ;
    HIV Med; 2012 May; 13(5):309-14. PubMed ID: 22151684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
    Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
    HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
    [No Abstract]   [Full Text] [Related]  

  • 14. Still a long wait for approved HIV-protective gel.
    Bateman C
    S Afr Med J; 2010 Sep; 100(9):560, 562. PubMed ID: 20822637
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics and pre-exposure prophylaxis for HIV infection.
    Sugarman J; Mayer KH
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S135-9. PubMed ID: 23764625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir alafenamide for HIV infection: is less more?
    Wyatt C; Baeten JM
    Lancet; 2015 Jun; 385(9987):2559-60. PubMed ID: 25890672
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
    Manfredi R; Calza L
    AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine-tenofovir tablets.
    Fulco PP; Ayala-Sims VA
    Am J Health Syst Pharm; 2014 May; 71(10):784, 786. PubMed ID: 24780482
    [No Abstract]   [Full Text] [Related]  

  • 19. Preexposure chemoprophylaxis for HIV prevention.
    Underhill K
    N Engl J Med; 2011 Apr; 364(14):1374; author reply 1374-5. PubMed ID: 21470023
    [No Abstract]   [Full Text] [Related]  

  • 20. Preexposure chemoprophylaxis for HIV prevention.
    Pittrof R; Sauer U; French P
    N Engl J Med; 2011 Apr; 364(14):1374; author reply 1374-5. PubMed ID: 21470022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.